PANDAA™ – a simple yet powerful innovation in genotyping technology.
PANDAA™ – a simple yet powerful innovation in genotyping technology.
Using our novel platform technology – Pan Degenerate Amplification and Adaptation – PANDAA™, Aldatu is able to take an already low-cost and sensitive diagnostic – known as qPCR – and enable it for HIV drug resistance genotyping. For the first time.
Sample InAnswer out
PANDAA™ HIV genotyping empowers healthcare providers with a solution to properly match HIV patients with effective drugs, thus improving patient outcomes and reducing the per-patient cost of HIV care.
Pan Degenerate Amplification and Adaptation (PANDAA) was developed by Iain MacLeod and Christopher Rowley at the Harvard School of Public Health.
Sample In
Answer out
PANDAA™ HIV genotyping empowers healthcare providers with a solution to properly match HIV patients with effective drugs, thus improving patient outcomes and reducing the per-patient cost of HIV care.
Pan Degenerate Amplification and Adaptation (PANDAA) was developed by Iain MacLeod and Christopher Rowley at the Harvard School of Public Health.